Binding of apob-containing lipoproteins from unfractionated human blood sera to immobilized LDL receptor

被引:0
|
作者
Inst of Experimental Cardiology, Moscow, Russia [1 ]
机构
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1367 / 1376
相关论文
共 50 条
  • [21] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. THERMAL STABILITY OF HUMAN PLASMA LDL(-): A PARADOXICAL BEHAVIOR OF LDL AGGREGATION
    Rull, A.
    Jayaraman, S.
    Rivas, A.
    Perez Cuellar, M.
    Ordonez Llanos, J.
    Sanchez Quesada, J. L.
    Gursky, O.
    ATHEROSCLEROSIS, 2016, 252 : E101 - E101
  • [22] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. MULTIPLE MODIFICATION OF LDL CIRCULATING IN BLOOD OF ATHEROSCLEROTIC PATIENTS
    Orekhov, A.
    Sobenin, I.
    Melnichenko, A.
    ATHEROSCLEROSIS, 2016, 252 : E102 - E102
  • [23] LPL meditated uptake of APOB100 but not of APOB48/E containing lipoproteins is dependent on LDL receptor
    Loeffler, B
    Heeren, J
    Schmid, J
    Greten, H
    Merkel, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 168 - 168
  • [24] The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins
    Maillard, Patrick
    Huby, Thierry
    Andreo, Ursula
    Moreau, Martine
    Chapman, John
    Budkowska, Agata
    FASEB JOURNAL, 2006, 20 (02): : 735 - +
  • [25] The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
    Christoffersen, Christina
    Benn, Marianne
    Christensen, Pernille M.
    Gordts, Philip L. S. M.
    Roebroek, Anton J. M.
    Frikke-Schmidt, Ruth
    Tybjaerg-Hansen, Anne
    Dahlback, Bjorn
    Nielsen, Lars B.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (10) : 2198 - 2204
  • [26] Immunoenzyme assessment of human ApoB-lipoprotein binding to immobilized receptor of low density lipoproteins .1. Preparation of anti-receptor monoclonal antibodies
    Tsibulsky, VP
    Yakushkin, VV
    Tikhomirov, OY
    Preobrazhensky, SN
    BIOCHEMISTRY-MOSCOW, 1997, 62 (06) : 596 - 602
  • [27] MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS
    Betteridge, J.
    Guyton, J. R.
    Farnier, M.
    Leiter, L. A.
    Lin, J.
    Shah, A.
    Johnson-Levonas, A. O.
    Brudi, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 163 - 164
  • [28] Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
    Fredrikson, Gunilla Nordin
    Berglund, Goran
    Alm, Ragnar
    Nilsson, Jan-Ake
    Shah, Prediman K.
    Nilsson, Jan
    JOURNAL OF LIPID RESEARCH, 2006, 47 (09) : 2049 - 2054
  • [29] Elevated postprandial lipemia and increased ApoB-containing lipoproteins in mice with single allele inactivation of hepatic lipolysis stimulated receptor (LSR): Evidence for link between hyperlipidemia, obesity, and atherosclerosis
    Yen, Frances T.
    Masson, Martial
    Roitel, Olivier
    Bonnard, Lionel
    Notet, Veronique
    Pratte, Dagmar
    Magueur, Erwan
    Bihain, Bernard E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E36 - E36
  • [30] The low density lipoprotein receptor prevents secretion of dense ApoB100-containing lipoproteins from the liver
    Larsson, SL
    Skogsberg, J
    Björkegren, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) : 831 - 836